InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by OLIPHANT LAURA, Director. Insider active across 1 company, notably Aehr Test Systems. Cumulatively, 10 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €599k. History available since 13 July 2021. The latest transaction was filed on 28 October 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
11,381 shares@ US$21.500.0067% mcap67.5% of flowCommon StockSEC:0001654954-21-011590
11,381 shares@ US$21.500.0067% mcap33.8% of flowCommon StockSEC:0001654954-21-011590:0
2,015 shares0Common StockSEC:0001654954-21-011235:0
2,015 shares0Common StockSEC:0001654954-21-011235
7,500 shares@ US$1.680.0003% mcap3.5% of flowCommon StockSEC:0001654954-21-009217
7,500 shares@ US$1.680.0003% mcap1.7% of flowCommon StockSEC:0001654954-21-009217:0
18,456 shares@ US$5.750.0029% mcap29.0% of flowCommon StockSEC:0001654954-21-008167
18,456 shares@ US$5.750.0029% mcap14.5% of flowCommon StockSEC:0001654954-21-008167:0
5,375 shares0Common StockSEC:0001654954-21-007933
5,375 shares0Common StockSEC:0001654954-21-007933:0
10 of 10 declarations
About OLIPHANT LAURA
Laura Oliphant serves as a Director for Aehr Test Systems. She brings expertise in technology and innovation to the board. Her experience in the semiconductor industry enables her to contribute to the company's strategy and guide key decisions.
